Chin Assessment and Augmentation
Read Article
Combining Botulinum Toxin and Dermal Filler Treatments in the Lower Face: A Face Shape-Based Approach
Achieving a harmonious lower-face result requires more than treating one line or one isolated area. The lower third of the face is shaped by bone, teeth, soft tissue, fat, retaining structures and muscle activity. As these elements change with age, treatment may require both muscle modulation and structural support.
Botulinum toxin and dermal filler can complement one another when they are selected and sequenced carefully. Botulinum toxin can reduce excessive downward or lateral muscle pull, while dermal filler can restore support, improve contour and address volume loss. The challenge is deciding which modality is appropriate, where it should be used and how the treatment should be adapted to the patient’s individual face shape.
Key Takeaways
- The lower face should be assessed as a functional and structural unit.
- Face shape influences diagnosis, treatment sequencing and the balance between muscle modulation and volumisation.
- Botulinum toxin changes muscle activity but does not replace lost volume.
- Dermal filler restores support and contour but does not correct all dynamic muscle pull.
- Combined treatment may produce more balanced and durable outcomes when used conservatively.
- Off-label use, informed consent, scope of practice and realistic expectations remain essential.
Why the Lower Face Changes With Age
The lower third of the face undergoes complex structural and functional changes over time. Mandibular resorption, reduced dental support, soft-tissue volume loss, fat-pad descent and changes in muscle balance can all contribute to:
- Jowling
- Marionette lines
- Downturned oral commissures
- Chin dimpling
- Loss of jawline definition
- Increased lower-face heaviness
These changes are rarely caused by a single anatomical factor. A patient may have structural volume loss, strong depressor activity and reduced chin support at the same time. Treating only one component may therefore produce an incomplete or unstable result.
Clinical Principle
Lower-face rejuvenation is most effective when practitioners distinguish between what is being pulled, what has descended and what has lost support.
Why Face Shape Matters
Face shape provides a framework for understanding proportion, width, length and where visual balance may be lost. It should not be used to force patients into a standardised aesthetic ideal. Instead, it helps practitioners identify how treatment may alter the relationship between the upper, middle and lower thirds of the face.
| Face Shape | Common Considerations | Possible Treatment Priorities |
|---|---|---|
| Round | Greater facial width and less vertical definition | Careful elongation, chin support and jawline refinement |
| Square | Strong masseter and lower-face width | Muscle assessment before adding further lateral volume |
| Heart-shaped | Narrower lower face with possible age-related imbalance | Chin, pre-jowl and lower-face support where indicated |
| Oblong | Greater vertical length and possible age-related elongation | Avoid excessive lengthening; restore balanced width and support |
| Oval | Generally balanced proportions with individual asymmetry or loss | Targeted correction without disturbing existing harmony |
Face shape should always be considered alongside profile, chin projection, dental support, skeletal relationships, asymmetry, sex characteristics and the patient’s own treatment goals.
The Role of Botulinum Toxin in the Lower Face
Botulinum toxin can be used to reduce excessive muscle activity that contributes to lower-face heaviness, chin dimpling, downward oral commissure pull or increased facial width. It does not provide volume or structural support.
Depressor Anguli Oris
The depressor anguli oris draws the corners of the mouth downward. Selective treatment may help reduce dynamic downturning and soften the appearance of a sad or stern expression.
Accurate placement is essential because nearby muscles contribute to lower-lip movement and oral function. Excessive spread may produce asymmetry or functional change.
Clinical Pearl
The DAO should rarely be assessed in isolation. Observe the patient speaking, smiling and at rest to determine whether the downward pull is primarily muscular or whether structural support has been lost. Treating the muscle without addressing volume loss—or vice versa—may produce an incomplete result.
Mentalis
The mentalis elevates and protrudes the lower lip and can create chin dimpling or a deep mental crease when hyperactive. Treatment may soften cobblestoning and improve the appearance of the chin, particularly when combined with structural support where required.
Clinical Pearl
Patients rarely present saying they have an overactive DAO or mentalis. They present with downturned oral commissures, marionette lines or chin dimpling. Before selecting a treatment, determine whether the concern is primarily driven by muscle activity, structural volume loss or a combination of both. This assessment will influence whether botulinum toxin, dermal filler or combined treatment is most appropriate.
Platysma
The platysma can contribute to downward pull along the jawline and to visible neck bands. Appropriate treatment may reduce some dynamic tension, but it does not correct all causes of jowling or skin laxity.
Masseter
Masseter treatment may reduce lower-face width in selected patients with true muscular hypertrophy and may also be used for some functional indications. Face shape and skeletal width must be assessed carefully before treatment. Reducing masseter volume in an already narrow or elongated face may worsen imbalance or reveal soft-tissue descent.
The Role of Dermal Filler in the Lower Face
Dermal filler can restore support, replace selected areas of volume loss and improve lower-face contour. Product selection and placement should reflect the treatment objective, tissue plane and anatomy.
Chin
Chin treatment may improve projection, length, contour and the relationship between the lower lip, chin and jawline. The plan should account for facial profile, dental occlusion and overall face shape.
Pre-Jowl Sulcus
Supporting the pre-jowl sulcus may improve continuity between the chin and mandibular border. However, filler should not be used to disguise significant tissue descent without considering the broader lower face.
Marionette Region
The marionette area may be influenced by volume loss, ligamentous change, skin laxity and dynamic pull. Direct filling may be appropriate in some cases, but treatment often benefits from first addressing the factors driving the fold.
Jawline
Jawline filler can improve definition and contour, but indiscriminate placement may add unnecessary width or heaviness. The patient’s existing mandibular shape, masseter size and lower-face proportions should guide the plan.
Why Combined Treatment Can Be More Effective
Botulinum toxin and dermal filler address different components of facial ageing. When used strategically, they can create a more balanced result than either modality used in isolation.
Examples include:
- Treating excessive DAO activity before or alongside support of the marionette region
- Reducing mentalis hyperactivity before chin augmentation
- Assessing and managing masseter hypertrophy before adding jawline definition
- Reducing selected platysmal pull while restoring support along the lower face
Why Sequence Matters
In some patients, muscle modulation should be allowed to take effect before final filler planning. In others, concurrent treatment may be suitable. The sequence should be determined by anatomy, treatment priority and the degree to which muscle activity is distorting the area.
Face Shape-Based Treatment Examples
Round Face
The objective may be to improve vertical balance rather than increase width. Chin projection or carefully planned jawline support may help, while masseter treatment should only be considered when genuine hypertrophy is present.
Square Face
A square lower face may reflect bone, muscle or both. If the masseters are dominant, muscle modulation may be considered before structural filler. Adding filler laterally without assessment may exaggerate width.
Heart-Shaped Face
Treatment may focus on restoring lower-face balance through selected chin, pre-jowl or jawline support. Excessive narrowing of the lower face should be avoided.
Oblong Face
Care is needed not to lengthen the face further. Treatment may aim to restore support and proportion without excessive vertical projection.
Oval Face
The aim is usually refinement rather than reshaping. Small, targeted corrections may preserve the patient’s existing balance while addressing asymmetry or localised age-related change.
Assessment Before Treatment
A lower-face treatment plan should be based on a full assessment rather than a single complaint. Useful observations include:
- Face shape and facial thirds
- Profile and chin projection
- Dental and skeletal relationships
- Masseter bulk at rest and contraction
- DAO and mentalis activity
- Platysmal recruitment
- Skin quality and laxity
- Jowl and pre-jowl anatomy
- Asymmetry
- Previous filler or toxin treatment
- Patient expectations and tolerance for staged treatment
Clinical Pearl
The most obvious fold is not always the primary treatment target. Look for the structural loss or muscular force that is creating it.
Consent, Scope of Practice and Off-Label Use
Some lower-face uses of botulinum toxin may be off-label, and approved indications vary between products. Practitioners must review the relevant product information and exercise appropriate clinical judgement.
The consultation and documentation should address:
- Whether the proposed use is off-label
- The reason treatment is being recommended
- Material risks and possible functional effects
- Alternative treatments, including no treatment
- The possibility of asymmetry, bruising, infection or unsatisfactory outcome
- The risks specific to dermal filler, including vascular compromise
- Expected longevity and the need for maintenance
- The staged nature of treatment where appropriate
Practitioners must also ensure that the proposed treatment falls within their professional scope, education, competence and insurance.
Patient Education and Expectations
Patients should understand that lower-face treatment is often a process rather than a one-session transformation. A phased plan can improve safety, control and patient satisfaction.
Important expectations to discuss include:
- More than one session may be required
- Botulinum toxin and filler have different onset and longevity
- Maintenance treatments are usually required
- The aim is to improve balance, not erase every line
- Natural correction is generally preferable to overcorrection
- Ageing, skin laxity and skeletal change may limit what injectables can achieve
Common Planning Mistakes
- Treating the marionette line without assessing DAO activity or structural support
- Adding jawline filler to a face that is already wide
- Reducing masseter volume in a narrow or elongated face
- Treating chin dimpling without considering chin projection
- Using filler to compensate for excessive muscle pull without addressing the muscle
- Attempting full correction in one session
- Using the same treatment sequence for every face shape
Frequently Asked Questions
Why combine botulinum toxin and dermal filler in the lower face?
Botulinum toxin reduces selected muscle activity, while dermal filler restores support and contour. Some patients have both dynamic and structural contributors to their concern, so combined treatment may be more appropriate.
Should botulinum toxin or filler be performed first?
It depends on the patient. When strong muscle activity is distorting the area, toxin may be performed first and the result reviewed before filler planning. In other cases, concurrent treatment may be appropriate.
Does face shape determine the treatment plan?
Face shape is one important consideration, but it should be assessed together with anatomy, profile, dental support, muscle activity, ageing changes and patient goals.
Can jawline filler make the lower face look wider?
Yes. Poorly planned lateral filler placement may add width or heaviness. Jawline treatment should be tailored to the patient’s existing proportions and masseter size.
Is masseter treatment suitable for every square face?
No. A square face may be caused by bone, muscle or both. Masseter treatment is only appropriate when muscular hypertrophy or a relevant functional indication is present.
Are lower-face botulinum toxin treatments off-label?
Some uses may be off-label, and indications differ between products. Practitioners should review the relevant product information and obtain appropriate informed consent.
Quick Summary
- Lower-face ageing involves both structural change and muscle activity.
- Face shape helps guide proportion, sequencing and treatment priorities.
- Botulinum toxin modulates muscle; dermal filler restores support and contour.
- Combined treatment can improve balance when planned conservatively.
- Assessment, consent, off-label discussion and scope of practice are essential.
Develop a Structured Lower-Face Treatment Plan
Effective lower-face treatment is not about adding product to every visible fold. It is about identifying the relationship between muscle activity, structural support, face shape and ageing.
Dermal Distinction Academy provides anatomy-led cosmetic injectable education for AHPRA-registered practitioners, with training in consultation, facial assessment, treatment planning, practical technique and complication prevention.
